danalcock, Author at European Medical Journal - Page 8 of 15

Healthcare Inequalities and the Exposome

Michelle Kelly-Irving joins Jonathan to speak about social, economic, and gender inequalities in healthcare, as well as the exposome.

Non-opioid pain medication wins FDA approval

FDA approved a new non-opioid medication for patients with post-operative pain who are being treated in hospital. Read more now.

Pharma in Ireland

The Irish pharmaceutical sector is expanding. Read more about what is driving companies to channel investment into the Emerald Isle.

The Dream for Women’s Healthcare

Byungyol ‘Bill’ Chun joins Jonathan to discuss labour and Caesarean section, abortion, menopause, and female healthcare in the USA.

Spotlight: September 2023

GOLD looks back at some of the top news stories from the pharmaceutical industry in the last month, covering opinion polls, landmark approvals and major projects on the horizon

Menopause: Rebranding Women’s Health – Part 2

In this episode, Jonathan is once again joined by Vikram Talaulikar, Associate Specialist in reproductive medicine at the University College London Hospitals (UCLH) NHS Foundation Trust, UK, to explore different treatment options for menopause, including lifestyle changes, alternative medicine, hormone replacement therapy, and non-hormonal treatments.

The curious paradox in cardiovascular disease

To mark World Heart Day 2023, how can the industry strike a balance between driving innovation and ensuring access to care for all?

Unraveling RSV: Structure, Transmission, Symptoms, and its Intersection with COVID

This podcast will delve into the intricacies of respiratory syncytial virus, exploring its symptoms and its relationship with the COVID pandemic.

Menopause: Rebranding Women’s Health – Part 1

Vikram Talaulikar joins Jonathan Sackier to discuss the menopause symptoms, how they vary over time, and possible treatments.

How to satisfy the curious key opinion leader

How can companies best leverage their KOLs earlier in the product lifecycle, and how do KOLs themselves want to involved?